Author(s):
T. Naga Ravi Kiran, A. V. S. Madhu Latha, J. N. Sureshkumar, E. Sagar Reddy
Email(s):
ravikirannaga58@gmail.com
DOI:
10.5958/2321-5836.2020.00013.0 
Address:
Dr. T. Naga Ravi Kiran, A. V. S. Madhu Latha, Dr. J. N. Sureshkumar, E. Sagar Reddy
Department of Pharmacy, Narasaraopeta Institute of Pharmaceutical Sciences, Narasaraopeta. A.P, India.
*Corresponding Author
Published In:
Volume - 12,
Issue - 2,
Year - 2020
ABSTRACT:
Novel coronavirus (nCoV) is one of the most common causes of respiratory tract infection throughout the world. Coronaviruses, a genus of the Corona viridae, are enveloped single positive-stranded RNA viruses, which have the largest viral genome (26-33kb) among the RNA viruses. nCoronaviruses cause a variety of diseases in mammals and birds ranging from enteritis in cows and pigs and upper respiratory disease chickens to potentially lethal human respiratory infections. Here we provide a brief introduction to coronaviruses discussing their replication and pathogenicity, and current prevention and treatment strategiesWe will also discuss the outbreaks of the highly pathogenic Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the recently identified Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) Were Also quoted.
Cite this article:
T. Naga Ravi Kiran, A. V. S. Madhu Latha, J. N. Sureshkumar, E. Sagar Reddy. Novel Coronavirus. Res. J. Pharmacology and Pharmacodynamics.2020; 12(2): 64-70. doi: 10.5958/2321-5836.2020.00013.0
Cite(Electronic):
T. Naga Ravi Kiran, A. V. S. Madhu Latha, J. N. Sureshkumar, E. Sagar Reddy. Novel Coronavirus. Res. J. Pharmacology and Pharmacodynamics.2020; 12(2): 64-70. doi: 10.5958/2321-5836.2020.00013.0 Available on: https://rjppd.org/AbstractView.aspx?PID=2020-12-2-4